| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |